Bio/Pharma Business

Lonza and Singzyme Enter Bioconjugates Partnership

November 02, 2022

Lonza and Singzyme will use Singzyme’s enzymatic conjugation platform to develop novel bioconjugates.

Purolite and Repligen Announce Ligand Partnership

November 01, 2022

Purolite and Repligen have extended their existing ligand partnership through 2032.

Societal CDMO Signs Multiple CDMO Service Agreements

October 25, 2022

Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.

GSK Expands Precision Medicine Collaboration with Tempus to Accelerate R&D

October 25, 2022

Under the new collaboration with Tempus, GSK will have access to de-identified patient data to accelerate drug discovery, improve clinical trial design, and speed up enrollment.

Gilead and MacroGenics Enter $1.7 Billion Oncology Collaboration

October 19, 2022

Gilead and MacroGenics will work together on bispecific antibodies for the treatment of blood cancers.

Merck and Moderna Enter $250 Million Cancer Vaccine Partnership

October 14, 2022

Merck has exercised a $250 million option with Moderna to jointly develop and commercialize cancer vaccine mRNA-4157/V940.

Alexion, AstraZeneca Acquire Genomic Medicines Company

October 14, 2022

Alexion’s acquisition of LogicBio is designed to accelerate the company’s growth in genomic medicines.

Lilly and Schrödinger Ink $425 Million Small Molecule Partnership

October 12, 2022

Eli Lilly and Company will partner with Schrödinger to develop and optimize small molecule compounds.

Cytiva Acquires CEVEC, Boosts Cell Line Development Capabilities

October 10, 2022

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

H.I.G. Capital Acquires Morningside Healthcare and Morningside Pharmaceuticals

October 06, 2022

H.I.G. Capital’s portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals.